<DOC>
	<DOCNO>NCT02085343</DOCNO>
	<brief_summary>This study test whether single session exposure therapy may enhance addition anti-phobic action beyond mere fade safety behavior . A total 100 acrophobic participant randomly assign receive standard exposure therapy ( EXP ) , exposure therapy safety behavior fading ( EXP + SBF ) , exposure safety behavior fade anti-phobic action ( EXP + SBF + AA ) , wait-list control group ( WL ) .</brief_summary>
	<brief_title>Anti-phobic Safety Behaviors Treatment Acrophobia</brief_title>
	<detailed_description>This study test whether single session exposure therapy may enhance addition one two augmentation strategy , include engagement anti-phobic action fade safety behavior . Because utilization safety behavior functionally preclude anti-phobic action , present study design replicate extend prior research address whether anti-phobic action enhance exposure therapy beyond mere fade safety behavior . A total 100 individual age 18 65 meeting DSM-IV criterion acrophobia ( fear height ) randomly assign one four condition include ( 1 ) standard exposure therapy , ( 2 ) exposure therapy safety behavior fading , ( 3 ) exposure therapy safety behavior fade anti-phobic action , ( 4 ) wait-list control condition . All participant complete online prescreen face-to-face screening assessment determine eligibility pre-treatment symptom severity . Participants also complete assessment post-treatment 1-month follow-up assessment . Subjective fear two behavioral approach test ( treatment generalization context , respectively ) conduct pre-treatment , post-treatment , 1-month follow-up assessment serve primary measure treatment outcome . Additionally , battery self-report questionnaire complete pre-treatment , treatment , post-treatment , 1-month follow-up assessment .</detailed_description>
	<criteria>1 . Age 18 65 . 2 . Fluent English ( write speak ) . This required assessment instrument validate English . 3 . Meet DSMIV criterion specific phobia , natural environment type , acrophobic concern , base Composite International Diagnostic Interview ( CIDIAuto ; World Health Organization , 1997 ) . 4 . Report moderate fear avoidance ( i.e. , score 30 high ) modify version Acrophobia Questionnaire ( AQ ; Cohen , 1977 ) . 5 . Exhibit least moderate fear ( i.e. , fear score 50 high , 0 = fear 100 = extreme fear ) two behavioral approach test ( BATs ) consist ascend two moderately challenge flight stair . 1 . Medical condition ( ) may prevent safely climb descend stair walk 15 minute time ( It necessary walk different sit behavioral approach test ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Exposure therapy</keyword>
	<keyword>Specific phobia</keyword>
	<keyword>Fear height</keyword>
	<keyword>Acrophobia</keyword>
	<keyword>Safety behavior fading</keyword>
	<keyword>Anti-phobic Actions</keyword>
</DOC>